|
[1]
|
Teamwork in Healthcare
2021
DOI:10.5772/intechopen.96063
|
|
|
|
|
[2]
|
Effects of nilotinib on platelet function in patients with chronic myeloid leukemia in chronic phase
Leukemia Research Reports,
2018
DOI:10.1016/j.lrr.2018.05.003
|
|
|
|
|
[3]
|
Lung cancer incidence in Sulaimani province during (2011–2015)
Journal of Cancer Policy,
2017
DOI:10.1016/j.jcpo.2017.09.007
|
|
|
|
|
[4]
|
On the use of substandard medicines in hematology: An emerging concern in the Middle East and North Africa region
European Journal of Internal Medicine,
2017
DOI:10.1016/j.ejim.2017.08.003
|
|
|
|
|
[5]
|
Patterns of Cancer in Kurdistan - Results of Eight Years Cancer Registration in Sulaymaniyah Province-Kurdistan-Iraq
Asian Pacific Journal of Cancer Prevention,
2016
DOI:10.7314/APJCP.2015.16.18.8525
|
|
|
|
|
[6]
|
Rebuttal and response to: “The efficacy and tolerability issue of generics of imatinib in the treatment of chronic myeloid leukemia: do generics really jeopardize patient safety?” by Ahmet Emre Eskazan, Muhlis Cem Ar and Teoman Soysal
Leukemia & Lymphoma,
2015
DOI:10.3109/10428194.2014.947757
|
|
|
|
|
[7]
|
Generics in chronic myeloid leukemia: current arguments for and against and the established evidence
Expert Review of Hematology,
2014
DOI:10.1586/17474086.2014.966679
|
|
|
|